Suppr超能文献

具有维生素D抵抗表型的新大陆灵长类动物B95 - 8细胞中类固醇结合的特异性。

Specificity of steroid binding in New World primate B95-8 cells with a vitamin D-resistant phenotype.

作者信息

Gacad M A, Adams J S

机构信息

Division of Endocrinology and Metabolism, Cedars-Sinai Medical Center, University of California School of Medicine, Los Angeles 90049.

出版信息

Endocrinology. 1992 Dec;131(6):2581-7. doi: 10.1210/endo.131.6.1446602.

Abstract

We recently described the existence of a competitive binding component in vitamin D-resistant New World primate cells that has a relatively low affinity (Kd, approximately 10(-8) M) but high capacity for 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] compared to that possessed by the vitamin D receptor (VDR). Here we show that this binding component is capable of binding a vitamin D3 metabolite other than 1,25-(OH)2D3 as well as steroid hormones structurally disparate from vitamin D3 sterols. We studied the binding of [3H]1,25-(OH)2D3 and [3H]25-hydroxyvitamin D3 ([3H]25OHD3) in extracts of the vitamin D-resistant marmoset lymphoblastic cell line B95-8 in the presence and absence of potential competitive ligands, including 25OHD3, 1,25-(OH)2D3, 17 beta-estradiol, testosterone, and progesterone, at concentrations ranging from 1-100 nM. Compared to extracts containing the authentic VDR, extracts of B95-8 cells bound 180% more 1,25-(OH)2D3 and 12-fold more 25OHD3 on a weight basis. The affinity of this binder for 25OHD3 was 2.2 times as great as its affinity for 1,25-(OH)2D3. Further, at concentrations approaching the Kd of this binder for 1,25-(OH)2D3, 25OHD3 was 3 times more effective than 1,25-(OH)2D3 in competing with [3H]1,25-(OH)2D3 for binding. This binder eluted from a Sephadex G-100 column with an apparent mol wt of 58 kilodaltons, and pooled elution fractions from the column encompassing this mol wt range were capable of inhibiting binding of 1,25-(OH)2D3 to the VDR by 65%. Competitive steroid binding analyses showed estradiol to be at least as effective as 1,25-(OH)2D3 in inhibition of [3H]1,25-(OH)2D3 binding; homologous binding studies with 17 beta-estradiol as labeled and competitive ligand demonstrated that concentrations of the gonadal steroid that successfully displaced [3H]1,25-(OH)2D3 also displaced 17 beta-[3H] estradiol. Using [3H]25OHD3 as the labeled ligand and a more extensive array of competitive ligands, the rank order of steroid binding was 25OHD3 > 1,25-(OH)2D3 > or = estradiol = progesterone = testosterone. These results suggest that the phenotype of steroid hormone resistance in New World primates may result from the overexpression of an intracellular 58-kilodalton protein(s) that interferes with the steroid-receptor interaction by competing for ligand binding.

摘要

我们最近描述了抗维生素D的新大陆灵长类动物细胞中存在一种竞争性结合成分,其亲和力相对较低(解离常数Kd约为10⁻⁸M),但与维生素D受体(VDR)相比,对1,25 - 二羟基维生素D3 [1,25-(OH)₂D3]具有高结合能力。在此我们表明,这种结合成分不仅能够结合1,25-(OH)₂D3以外的维生素D3代谢物,还能结合结构上与维生素D3甾醇不同的类固醇激素。我们研究了在存在和不存在潜在竞争性配体(包括25OHD3、1,25-(OH)₂D3、17β - 雌二醇、睾酮和孕酮,浓度范围为1 - 100 nM)的情况下,抗维生素D的狨猴淋巴母细胞系B95 - 8提取物中[³H]1,25-(OH)₂D3和[³H]25 - 羟基维生素D3([³H]25OHD3)的结合情况。与含有真实VDR的提取物相比,B95 - 8细胞提取物以重量计结合的1,25-(OH)₂D3多180%,结合的25OHD3多12倍。这种结合剂对25OHD3的亲和力是其对1,25-(OH)₂D3亲和力的2.2倍。此外,在接近这种结合剂对1,25-(OH)₂D3的Kd浓度时,25OHD3在与[³H]1,25-(OH)₂D3竞争结合方面比1,25-(OH)₂D3有效3倍。这种结合剂从Sephadex G - 100柱上洗脱时表观分子量为58千道尔顿,汇集该柱上包含此分子量范围的洗脱级分能够抑制1,25-(OH)₂D3与VDR的结合达65%。竞争性类固醇结合分析表明,雌二醇在抑制[³H]1,25-(OH)₂D3结合方面至少与1,25-(OH)₂D3一样有效;以17β - 雌二醇作为标记和竞争性配体的同源结合研究表明,成功取代[³H]1,25-(OH)₂D3的性腺类固醇浓度也能取代17β - [³H]雌二醇。使用[³H]25OHD3作为标记配体以及更广泛的一系列竞争性配体,类固醇结合的顺序为25OHD3 > 1,25-(OH)₂D3 ≥ 雌二醇 = 孕酮 = 睾酮。这些结果表明,新大陆灵长类动物中类固醇激素抵抗的表型可能是由于一种细胞内58千道尔顿蛋白质的过度表达,该蛋白质通过竞争配体结合来干扰类固醇 - 受体相互作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验